INTERFERON LAMBDA THERAPY FOR TREATMENT OF RESPIRATORY DISEASES

摘要

The present invention relates to use of one or more interferon lambdas (IFN-?s), also known as IL-29 and IL28a/b, for alleviating or preventing viral-induced exacerbation of a respiratory disorder, especially for example exacerbation of asthma arising from viral infection, most commonly rhino virus infection.